Skip to content
ISBN: 0471971170
ISBN13: 9780471971177

Modern Strategy for Preclinical Pharmaceutical R&d: Towards the Virtual Research Company

$268.26List Price: $312.95
Save $44.69!
ISBN: 0471971170
ISBN13: 9780471971177
Formats

Conditions

A brand-new, unused copy in perfect condition.

Formats

Conditions

A brand-new, unused copy in perfect condition.

See all 1 editionsfrom $268.26

Book Overview

The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small "biotechnology" companies and "research boutiques," and possibly even the "virtual research company" might play as contractors and collaborators.
Format:
Hardcover
Language:
English
ISBN:
0471971170
ISBN13:
9780471971177
Release Date:
March 1997
Publisher:
Wiley & Sons, Incorporated, John
Length:
231 Pages
Weight:
1.10 lbs.
Dimensions:
0.8″ × 6.0″ × 9.6″
Allied Health ServicesBasic SciencesMedicalMedical BooksPharmacologyPharmacy

More by David Cavalla

Customer Reviews

0 customer ratings | 0 reviews
Write a Review

There are currently no reviews. Be the first to review this work.